Myfortic (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the Myfortic drug offered from Novartis Pharmaceuticals Corporation. This Antimetabolite Immunosuppressant [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
| NON-PROPRIETARY NAME: | mycophenolic acid |
| SUBSTANCE NAME: | MYCOPHENOLATE SODIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Antimetabolite Immunosuppressant [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, DELAYED RELEASE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2004-02-27 |
| END MARKETING DATE: | 0000-00-00 |
Myfortic HUMAN PRESCRIPTION DRUG Details:
| Item Description | Myfortic from Novartis Pharmaceuticals Corporation |
| LABELER NAME: | Novartis Pharmaceuticals Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 180(mg/1) |
| START MARKETING DATE: | 2004-02-27 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0078-0385_dd77b077-1906-4e70-8c38-356e242aa9a4 |
| PRODUCT NDC: | 0078-0385 |
| APPLICATION NUMBER: | NDA050791 |
Other MYCOPHENOLATE SODIUM Pharmaceutical Manufacturers / Labelers:
